FDA Inspection 1164264 - Olympus Corporation of the Americas - March 10, 2022

FDA Inspection 1164264 for Olympus Corporation of the Americas on March 10, 2022. Classification: Voluntary Action Indicated (VAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1164264 for Olympus Corporation of the Americas on March 10, 2022. Classification: Voluntary Action Indicated (VAI).

Violation Codes

21 CFR 803.17(a)(1)

21 CFR 820.100(a)

21 CFR 820.198(a)

21 CFR 820.25(a)

21 CFR 820.75(a)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Olympus Corporation of the Americas

Inspection Date

March 10, 2022

Product Type

Devices

Office

Center for Devices and Radiological Health

ID: fe5c8d7e-436d-4be4-801b-698b99ac72e4

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox